Date
Location
This is the sixth in a series of regular meetings between regulators and representatives of industry stakeholder organisations. It addresses all areas of product-development support, from scientific advice and innovation support, as well as specifics for paediatric and orphan medicines.
This meeting focuses on combination products with medical devices / companion diagnostics, assessment of similarity for ATMPs, progressing the concept of patient-centred development in practice, scientific advice for continuous innovation in known molecules, 5-year review of the PRIME scheme and a status update from the ongoing discussions at the focus groups for Practical application of integrated development support and Concept of an ‘evolutionary’ PIP.